Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A Bartley

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Analytical Biochemistry|November 3, 2010
Antisense PCR: A simple and robust method for performing nested single-tube PCRMichael J Brisco, Paul A Bartley, Alexander A Morley
Analytical Biochemistry|January 16, 2010
Gene walking using sequential hybrid primer polymerase chain reactionMichael H Martin-Harris, Paul A Bartley, Alexander A Morley
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
Absence of platelet endothelial cell adhesion molecule-1 (CD31) leads to increased severity of local and systemic IgE-mediated anaphylaxis and modulation of mast cell activationMae-Xhum Wong, Donna Roberts, Paul A Bartley, et al.
Biotechniques|December 15, 2010
Incorporation of measurement of DNA integrity into qPCR assaysMichael J Brisco, Sue Latham, Paul A Bartley, et al.
Oncogene|October 25, 2003
Regulation of the gene encoding glutathione S-transferase M1 (GSTM1) by the Myb oncoproteinPaul A Bartley, Rebecca A Keough, Jodi K Lutwyche, et al.
Blood|June 19, 2002
Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune diseaseRay Wilkinson, A Bruce Lyons, Donna Roberts, et al.
British Journal of Haematology|January 14, 2010
Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemiaPaul A Bartley, Michael H Martin-Harris, Bradley J Budgen, et al.
Haematologica|August 11, 2011
Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease featuresDavid M Ross, Paul A Bartley, Jarrad Goyne, et al.
Journal of Clinical Pathology|February 4, 2016
BCR-ABL1 expression, RT-qPCR and treatment decisions in chronic myeloid leukaemiaSusan Latham, Paul A Bartley, Bradley Budgen, et al.
The Journal of Molecular Diagnostics : JMD|January 3, 2015
A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemiaPaul A Bartley, Susan Latham, Bradley Budgen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Analytical Biochemistry|November 3, 2010
Antisense PCR: A simple and robust method for performing nested single-tube PCRMichael J Brisco, Paul A Bartley, Alexander A Morley
Analytical Biochemistry|January 16, 2010
Gene walking using sequential hybrid primer polymerase chain reactionMichael H Martin-Harris, Paul A Bartley, Alexander A Morley
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
Absence of platelet endothelial cell adhesion molecule-1 (CD31) leads to increased severity of local and systemic IgE-mediated anaphylaxis and modulation of mast cell activationMae-Xhum Wong, Donna Roberts, Paul A Bartley, et al.
Biotechniques|December 15, 2010
Incorporation of measurement of DNA integrity into qPCR assaysMichael J Brisco, Sue Latham, Paul A Bartley, et al.
Oncogene|October 25, 2003
Regulation of the gene encoding glutathione S-transferase M1 (GSTM1) by the Myb oncoproteinPaul A Bartley, Rebecca A Keough, Jodi K Lutwyche, et al.
Blood|June 19, 2002
Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune diseaseRay Wilkinson, A Bruce Lyons, Donna Roberts, et al.
British Journal of Haematology|January 14, 2010
Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemiaPaul A Bartley, Michael H Martin-Harris, Bradley J Budgen, et al.
Haematologica|August 11, 2011
Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease featuresDavid M Ross, Paul A Bartley, Jarrad Goyne, et al.
Journal of Clinical Pathology|February 4, 2016
BCR-ABL1 expression, RT-qPCR and treatment decisions in chronic myeloid leukaemiaSusan Latham, Paul A Bartley, Bradley Budgen, et al.
The Journal of Molecular Diagnostics : JMD|January 3, 2015
A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemiaPaul A Bartley, Susan Latham, Bradley Budgen, et al.
Pageof 2